Click for new scientific resources and news about Corona[COVID-19]

Use Online Translation Powered By

Click Here STRS

STRS

Paper Information
Journal:   IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)   JANUARY 2010 , Volume 4 , Number 1; Page(s) 74 To 77.
 
Paper: 

SURVIVAL AT 1, 3, AND 5 YEARS IN DIABETIC AND NONDIABETIC PATIENTS ON HEMODIALYSIS
 
 
Author(s):  BELADI MOUSAVI SEYED SEYF ELAH*, HAYATI F., ALEMZADEH ANSARI M.J., VALAVI E., CHERAGHIAN B., SHAHBAZIAN H.A., GOLZARI KH., GHORBANI ALI, RASHIDI H., PAYAMI SEYED PEYMAN, GHADERIAN B., EYDENI E.
 
* DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES, AHVAZ, IRAN
 
Abstract: 

We analyzed survival of 185 adult patients on maintenance hemodialysis (9 h/wk to 12 h/wk) at Emam Khomini Hospital in Ahvaz, Iran. Patient survival at 1, 3, and 5 years was 89.2%, 69.2%, and 46.8%, respectively. There was no significant difference between diabetic and nondiabetic patients in 1-year survival (87.1% versus 89.7%, P = .66). But, 3- and 5-year survival rates of diabetic patients were significantly lower than those of nondiabetic patients (52.2% versus 73.8%, P = .04; zero versus 56.9%, P < .001; respectively). Based on our findings, the survival of diabetic patients undergoing hemodialysis was much worse than survival of nondiabetic patients. Thus, prevention of diabetic nephropathy should be more emphasized; and if end-stage renal disease is present, other renal replacement therapies such as kidney transplantation must be considered as soon as possible.
 
Keyword(s): DIABETIC NEPHROPATHY, END-STAGE RENAL DISEASE, HEMODIALYSIS, SURVIVAL
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
 
+ Click to Cite.
APA: Copy

BELADI MOUSAVI, S., & HAYATI, F., & ALEMZADEH ANSARI, M., & VALAVI, E., & CHERAGHIAN, B., & SHAHBAZIAN, H., & GOLZARI, K., & GHORBANI, A., & RASHIDI, H., & PAYAMI, S., & GHADERIAN, B., & EYDENI, E. (2010). SURVIVAL AT 1, 3, AND 5 YEARS IN DIABETIC AND NONDIABETIC PATIENTS ON HEMODIALYSIS. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 4(1), 74-77. https://www.sid.ir/en/journal/ViewPaper.aspx?id=172211



Vancouver: Copy

BELADI MOUSAVI SEYED SEYF ELAH, HAYATI F., ALEMZADEH ANSARI M.J., VALAVI E., CHERAGHIAN B., SHAHBAZIAN H.A., GOLZARI KH., GHORBANI ALI, RASHIDI H., PAYAMI SEYED PEYMAN, GHADERIAN B., EYDENI E.. SURVIVAL AT 1, 3, AND 5 YEARS IN DIABETIC AND NONDIABETIC PATIENTS ON HEMODIALYSIS. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD). 2010 [cited 2021June21];4(1):74-77. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=172211



IEEE: Copy

BELADI MOUSAVI, S., HAYATI, F., ALEMZADEH ANSARI, M., VALAVI, E., CHERAGHIAN, B., SHAHBAZIAN, H., GOLZARI, K., GHORBANI, A., RASHIDI, H., PAYAMI, S., GHADERIAN, B., EYDENI, E., 2010. SURVIVAL AT 1, 3, AND 5 YEARS IN DIABETIC AND NONDIABETIC PATIENTS ON HEMODIALYSIS. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), [online] 4(1), pp.74-77. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=172211.
 
  pdf-File
Yearly Visit 101
 
 
Latest on Blog
Enter SID Blog